BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35202551)

  • 1. An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery.
    Stanicki D; Vangijzegem T; Ternad I; Laurent S
    Expert Opin Drug Deliv; 2022 Mar; 19(3):321-335. PubMed ID: 35202551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
    Vangijzegem T; Stanicki D; Laurent S
    Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
    Mohammed L; Ragab D; Gomaa H
    Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in iron oxide nanoparticles for brain cancer theranostics: from
    Sheervalilou R; Shirvaliloo M; Sargazi S; Ghaznavi H
    Expert Opin Drug Deliv; 2021 Jul; 18(7):949-977. PubMed ID: 33567919
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic nanoparticles for cancer theranostics: Advances and prospects.
    Li X; Li W; Wang M; Liao Z
    J Control Release; 2021 Jul; 335():437-448. PubMed ID: 34081996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview and bibliometric analysis on the colorectal cancer therapy by magnetic functionalized nanoparticles for the responsive and targeted drug delivery.
    Darroudi M; Gholami M; Rezayi M; Khazaei M
    J Nanobiotechnology; 2021 Nov; 19(1):399. PubMed ID: 34844632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of Magnetic Nanoparticles in Targeted Drug Delivery System.
    Mou X; Ali Z; Li S; He N
    J Nanosci Nanotechnol; 2015 Jan; 15(1):54-62. PubMed ID: 26328305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Applications of Superparamagnetic Iron Oxide Nanoparticles in Novel Drug Delivery Systems: An Overview.
    Hooshmand S; Hayat SMG; Ghorbani A; Khatami M; Pakravanan K; Darroudi M
    Curr Med Chem; 2021; 28(4):777-799. PubMed ID: 31971104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic lipid-based hybrid nanosystems for drug delivery.
    Millart E; Lesieur S; Faivre V
    Expert Opin Drug Deliv; 2018 May; 15(5):523-540. PubMed ID: 29543082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
    Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
    Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
    Wahajuddin ; Arora S
    Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Metallic Nanoparticles in the Skin Cancer Treatment.
    Marzi M; Osanloo M; Vakil MK; Mansoori Y; Ghasemian A; Dehghan A; Zarenezhad E
    Biomed Res Int; 2022; 2022():2346941. PubMed ID: 36420097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensors and Drug Delivery in Oncotheranostics Using Inorganic Synthetic and Biogenic Magnetic Nanoparticles.
    Zimina TM; Sitkov NO; Gareev KG; Fedorov V; Grouzdev D; Koziaeva V; Gao H; Combs SE; Shevtsov M
    Biosensors (Basel); 2022 Sep; 12(10):. PubMed ID: 36290927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases.
    El-Sherbiny IM; Elbaz NM; Sedki M; Elgammal A; Yacoub MH
    Nanomedicine (Lond); 2017 Feb; 12(4):387-402. PubMed ID: 28078950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione conjugated polyethylenimine on the surface of Fe
    Aeineh N; Salehi F; Akrami M; Nemati F; Alipour M; Ghorbani M; Nikfar B; Salehian F; Riyahi Alam N; Sadat Ebrahimi SE; Foroumadi A; Khoobi M; Rouini M; Dibaei M; Haririan I; Ganjali MR; Safaei S
    J Biomater Sci Polym Ed; 2018 Jul; 29(10):1109-1125. PubMed ID: 29320951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in surface design and biomedical applications of magnetic nanoparticles.
    Araújo EV; Carneiro SV; Neto DMA; Freire TM; Costa VM; Freire RM; Fechine LMUD; Clemente CS; Denardin JC; Dos Santos JCS; Santos-Oliveira R; Rocha JS; Fechine PBA
    Adv Colloid Interface Sci; 2024 Jun; 328():103166. PubMed ID: 38728773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.